

Paxlovid can cost over $1,300 without insurance. Learn how to save with coupons, discount cards, Pfizer's patient assistance program, and more in 2026.
If you've been prescribed Paxlovid (Nirmatrelvir/Ritonavir) for COVID-19 and just learned the price, you're probably in shock. A single 5-day course of Paxlovid costs approximately $1,200 to $1,500 at retail price — a far cry from the early pandemic days when the government provided it for free.
The good news? There are real ways to reduce what you pay for Paxlovid. In this guide, we'll break down the costs, walk you through every savings option available in 2026, and help you figure out the best path for your situation.
Let's start with the numbers. If you're paying cash (no insurance), here's what to expect:
This is a brand-name medication with no generic competition, which is the primary reason the price is so high. Unlike many medications where a generic alternative can save you 80–90%, Paxlovid's pricing has limited competitive pressure in the U.S. market.
If you have health insurance, your cost will depend on your specific plan:
Pharmacy discount cards and coupon programs can help reduce the cash price of Paxlovid, though savings on a high-cost branded product are typically more modest than what you'd see for generic medications. Here are options to explore:
Pfizer has offered co-pay assistance programs for commercially insured patients that can reduce your out-of-pocket cost to as low as $0. Check paxlovid.com or call Pfizer at 1-800-706-2400 to see if a co-pay card is currently available for Paxlovid.
Several pharmacy discount programs may offer reduced pricing on Paxlovid:
Keep in mind: discount cards typically save 5–15% on expensive brand-name medications, which might bring the price down by $60–$200. That's meaningful but won't make the same dramatic difference you'd see with generic drugs.
Don't assume every pharmacy charges the same price. Paxlovid cash prices can vary significantly:
Use Medfinder to find pharmacies with Paxlovid in stock, then call to compare prices before you fill.
If cost is the primary barrier to getting Paxlovid, patient assistance programs (PAPs) may provide the medication at no cost. These programs are specifically designed for uninsured and underinsured patients.
This is the most important program to know about for Paxlovid:
Some physicians' offices and clinics may have Paxlovid sample stock available for patients who face financial barriers. It doesn't hurt to ask your prescriber.
Some employers offer supplemental pharmacy benefits, health reimbursement arrangements (HRAs), or flexible spending accounts (FSAs) that can be used toward prescription costs. If you have an FSA or HSA, Paxlovid is an eligible expense.
If your insurance copay seems unreasonably high, call your insurance company and ask about:
Some telehealth platforms that prescribe Paxlovid offer bundled visit-and-medication pricing that may be competitive with the retail pharmacy price. Compare the total cost (visit fee + medication) before committing.
At $1,200–$1,500 retail, Paxlovid is one of the more expensive prescriptions you might encounter. But between Pfizer's patient assistance program, insurance coverage, pharmacy discount cards, and other savings strategies, most patients can find a way to make it affordable — or even free.
Start by checking your insurance coverage, then explore Pfizer RxPathways if you're uninsured. Use discount cards as a backup, and don't be afraid to compare prices across pharmacies. Time is critical with Paxlovid, so start working on the cost question as soon as you get your prescription.
Need help finding a pharmacy with Paxlovid in stock? Visit Medfinder to search real-time availability near you. For more about this medication, check out our guide on what Paxlovid is and how it works.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.